A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's Syndrome
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to argenx
Related studies linked through entity extraction aliases.
A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Assess Adults With CIDP Transitioning From IVIg to Efgartigimod PH20 SC
- Status
- COMPLETED
- Phase
- PHASE4
A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular Myasthenia Gravis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Evaluate the Safety and Tolerability of Efgartigimod PH20 SC Given by Prefilled Syringe in Kidney Transplant Recipients With Antibody-Mediated Rejection (AMR)
- Status
- RECRUITING
- Phase
- PHASE2
Efgartigimod for the Treatment of Acute Optic Neuritis
- Status
- RECRUITING
- Phase
- PHASE2
A Safety and Efficacy Study of ARGX-119 in Adult Patients With Amyotrophic Lateral Sclerosis (ALS)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Phase 1b Study to Investigate Safety and Tolerability of ARGX-119 in Adult Participants With DOK7-Congenital Myasthenic Syndromes (CMS)
- Status
- RECRUITING
- Phase
- PHASE1
A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Study of Efgartigimod PH20 SC Given by Prefilled Syringe in Adults With Thyroid Eye Disease.
- Status
- TERMINATED
- Phase
- PHASE3
A Study of Efgartigimod PH20 SC Given by Prefilled Syringe in Adults With Thyroid Eye Disease
- Status
- TERMINATED
- Phase
- PHASE3
A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
- Status
- RECRUITING
- Phase
- N/A
A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
- Status
- RECRUITING
- Phase
- N/A
A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study to Evaluate Safety and Efficacy of Empasiprubart in Adults With Dermatomyositis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Open-Label Extension Study to Evaluate the Safety of Efgartigimod in Adult Patients With Primary Sjögren's Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
A Natural History Study in Participants With Congenital Myasthenic Syndromes (CMS) Due to Mutations in DOK7, MUSK, AGRN, or LRP4
- Status
- RECRUITING
- Phase
- N/A
A Prospective Longitudinal Study in Adults With Multifocal Motor Neuropathy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE3